MS Briefs

Depression, Fatigue, and Cognitive Functioning in MS

Mult Scler Relat Disord; ePub 2019 Jan 31; Hughes


 

In the presence of mild levels of depression or significant fatigue in persons with multiple sclerosis (MS), subjective cognitive measures are unlikely to provide accurate estimates of objective cognitive functioning. This according to a recent study that aimed to examine the degree to which depressive symptoms and fatigue in individuals with MS are associated with discrepancies between subjective and objective cognitive impairment. 99 adults with MS completed the Patient Health Questionnaire–8 (PHQ-8), Fatigue Severity Scale (FSS), MS Neuropsychological Screening Questionnaire (MSNQ), and Brief International Cognitive Assessment for MS (BICAMS). Participants were classified as “Accurates,” “Underestimators,” or “Overestimators” based on discrepancies between their MSNQ (subjective) and BICAMS (objective) scores. Researchers found:

  • The PHQ-8 ( r=.58) and FSS ( r=.48) significantly correlated with the MSNQ, but not with the
    BICAMS ( rs<.07).
  • Underestimators (ie, participants who underestimated their objective cognitive functioning) exhibited higher PHQ-8 and FSS scores compared to Accurates and Overestimators.
  • Optimal cut-scores of ≥6 on the PHQ-8 and ≥36 on the FSS provided fair accuracy (78% and 74%) for identifying Underestimators.
  • Identification of Underestimators based on PHQ-8 and FSS scores was not moderated by any demographic or MS clinical variables.

Hughes AJ. Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis. [Published online ahead of print January 31, 2019]. Mult Scler Relat Disord. doi:10.1016/j.msard.2019.01.055.

Recommended Reading

Daclizumab beta may be superior to interferon beta on MS disability progression
ICYMI Multiple Sclerosis
Interferon Beta May Not Affect Pregnancy Outcomes in MS
ICYMI Multiple Sclerosis
Autologous Hematopoietic Stem Cells May Treat Aggressive MS Effectively
ICYMI Multiple Sclerosis
DMTs, stem cell transplants both reduce disease progression in MS
ICYMI Multiple Sclerosis
Examining Pseudobulbar Affect in Multiple Sclerosis
ICYMI Multiple Sclerosis
Body Composition, Disability in People with MS
ICYMI Multiple Sclerosis
Core Temperature Not Elevated at Rest in RRMS
ICYMI Multiple Sclerosis
Interview with Joseph R. Berger, MD, on the Financial Contribution of the MS Specialist
ICYMI Multiple Sclerosis
Global Burden of Multiple Sclerosis, 1990-2018
ICYMI Multiple Sclerosis
Trait Conscientiousness and SDMT Decline in MS
ICYMI Multiple Sclerosis